من نحن

At Novo Genomics, we are honored to be at the forefront of precision medicine in Saudi Arabia and the Middle East. Our journey is guided by a single vision: harnessing the power of genomics, data science, and next-generation biotechnology to transform healthcare delivery, improve patient outcomes, and contribute to a knowledge-based, innovation-driven economy.

As a Saudi-born biotechnology company, we are deeply committed to developing scientifically rigorous, regionally relevant, and clinically impactful solutions. Through investments in local research, strategic international collaborations, and cutting-edge technologies, we address critical gaps in diagnostics, preventative care, and population health—while maintaining the highest standards of quality, ethics, and data integrity.

We are proud to support healthcare institutions, physicians, and patients with a growing portfolio of genomic innovations that align with the Kingdom’s national priorities and the aspirations of Vision 2030. We also believe that sustainable impact requires strategic collaboration—with government stakeholders, academic institutions, and the global scientific community.

At Novo Genomics, we are driven by purpose, powered by science, and inspired by the opportunity to shape the future of healthcare in the region and beyond. We thank you for your continued trust.

Best regards,
Dr. Abdulelah Al-Hawsawi,
CEO,
Novo Genomics